Abaloparatide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Abaloparatide
Description :
Abaloparatide (BA 058) is a parathyroid hormone receptor 1 (PTHR1) analog. Abaloparatide also is a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide has the potential for the research of osteoporosis[1][2].Product Name Alternative :
BA 058; BIM 44058UNSPSC :
12352209Target :
Arrestin; PTHRType :
PeptidesRelated Pathways :
GPCR/G ProteinApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Metabolic Disease; CancerAssay Protocol :
https://www.medchemexpress.com/abaloparatide.htmlPurity :
99.91Solubility :
DMSO : 25 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mLSmiles :
O=C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(NC(C)(C)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC3=CNC=N3)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)NMolecular Formula :
C174H300N56O49Molecular Weight :
3960.59References & Citations :
[1]Sahbani K, et al. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide. Physiol Rep. 2019 Oct;7 (19) :e14225.|[2]Varela A, et al. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption. J Bone Miner Res. 2017 Jan;32 (1) :24-33.Shipping Conditions :
Blue IceStorage Conditions :
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)Scientific Category :
PeptidesClinical Information :
LaunchedCitation 01 :
BMC Oral Health. 2025 Sep 29;25 (1) :1492.|Proc Natl Acad Sci U S A. 2021 Nov 9;118 (45) :e2107363118.CAS Number :
[247062-33-5]

